Reporter

Sternberg to step down after two decades at Vanderbilt

Paul Sternberg Jr., MD, is stepping down from his role as chair of the Department of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute, effective June 30, 2023.

Nanoparticles boost anti-cancer immunity

An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.

Mitochondria and retinal degeneration

Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.

Jeff Balser, MD, PhD, discussed results of VUMC’s Culture Survey during the Leadership Assembly.

Supporting ‘Team VUMC’: Leadership Assembly Highlights

Growth across both Vanderbilt University Medical Center and the communities it serves spotlights the need to bolster collaboration and communication to efficiently provide care to patients and ensure well-being of the workforce, Medical Center leaders said during streaming of the August 2022 Leadership Assembly.

Genotype-specific blood counts

Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts.

Cell-free breast cancer “biopsy”

The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.

1 83 84 85 86 87 770